G

C

GUDIOL , C.

Last name: GUDIOL

First name: C.

2018 (v1)

Publication

Metadata-only

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4)

Drgona, L. Gudiol, C. Lanini, S.

Background: The present review is part of the ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies. Aims: To review, from an Infectious Diseases perspective, the safety profile of agents targeting CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4 and to suggest...

Uploaded on: April 14, 2023
December 1, 2022 (v1)

Publication

Metadata-only

Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study

Gudiol, C. Durà-Miralles, X. Aguilar-Company, J.

Background: We aimed to describe the epidemiology, risk factors, and clinical outcomes of co-infections and superinfections in onco-hematological patients with COVID-19. Methods: International, multicentre cohort study of cancer patients with COVID-19. All patients were included in the analysis of co-infections at diagnosis, while only patients...

Uploaded on: March 24, 2023